Mycobacterium Tuberculosis-IN-7
Mycobacterium Tuberculosis-IN-7 (Compound 4c) inhibits M. tuberculosis H37Ra with MIC of 5.34 μg/mL. Mycobacterium Tuberculosis-IN-7 exhibits slight cytotoxicity in cancer cell Vero, A549, and HepG2 (IC50s >50 μM) [1].
Product Specifications
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
COC1=C(NC2=NN(CCCC)C=C2)C(OC)=CC=C1
Molecular Formula
C15H21N3O2
Molecular Weight
275.35
References & Citations
[1]Wan G, et al., Discovery of 1,3-Disubstituted Pyrazole derivatives as Mycobacterium tuberculosis inhibitors. Bioorg Med Chem Lett. 2025 Feb 28;121:130156.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-172397/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1084039-01 0.02 mg (E-Coli)
Recombinant Escherichia coli Uncharacterized protein ypjK (ypjK)
Ask
View Details 
MBS1084039-02 0.1 mg (E-Coli)
Recombinant Escherichia coli Uncharacterized protein ypjK (ypjK)
Ask
View Details MBS1084039-03 0.02 mg (Yeast)
Recombinant Escherichia coli Uncharacterized protein ypjK (ypjK)
Ask
View Details MBS1084039-04 0.1 mg (Yeast)
Recombinant Escherichia coli Uncharacterized protein ypjK (ypjK)
Ask
View Details MBS1084039-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli Uncharacterized protein ypjK (ypjK)
Ask
View Details 
MBS1084039-06 1 mg (E-Coli)
Recombinant Escherichia coli Uncharacterized protein ypjK (ypjK)
Ask
View Details